DCBLD2 and neoplasm: We also mixed DCBLD2-overexpessing A549 cells and empty vector-transfected cells at a ratio of 1:1 before injecting them subcutaneously into mice to generate the tumor xenografts composed of cells with heterogeneous expression of DCBLD2.